Ranbaxy may have to pay huge fine, again
Ranbaxy Laboratories, set to be merged with Sun Pharmaceutical Industries, might again have to pay a hefty penalty to the US authorities for alleged violations at its Toansa factory in Punjab. The facility
Ranbaxy Pharmaceuticals
-
Pfizer Marketing May Hit Ranbaxy Earnings from Lipitor Clone
Aggressive marketing initiatives by Pfizer Inc may reduce Ranbaxy Laboratories’ earnings from the scheduled launch of its lowcost version of Lipitor, the world’s largest selling drug, in the US by the
-
Ranbaxy Gets Nod for Ist Drug Developed by Indian Pharma Co
The country’s drug regulator has given conditional market approval for Ranbaxy Laboratories’ anti-malaria drug, paving the way for the launch of the country’s first privately-developed medicine and ending
-
Pfizer, Dr Reddy’s Settle Patent Suit over Lipitor
Pfizer Inc and Dr Reddy’s Laboratories have settled a patent infringement suit related to the Indian drug maker’s launch of a generic version of the blockbuster drug, Lipitor, in the US. Pfizer’s Lipitor
-
Ranbaxy, Daiichi Sankyo to run mobile health clinics
Daiichi Sankyo Company and Ranbaxy Laboratories Ltd on Wednesday announced an initiative to sponsor mobile healthcare field clinics in India, Cameroon and Tanzania as part of their global social contribution
-
Ranbaxy to spend ¥200 m on mobile clinics
Drug major Ranbaxy On Wednesday said it will spend nearly ¥200 million (over Rs 10 crore) along with parent company Daiichi Sankyo over the next five years to sponsor mobile healthcare field clinics in
-
FDA Checks Indian Drug Plants
No major deficiency found during inspection of Ranbaxy, Orchid, Emcure, Nectar & Ind Swift Facilities The US drug regulator has inspected manufacturing plants of at least half a dozen Indian drugmakers in the last few weeks, raising hopes among some of these companies that they will shortly be able to export medicines to the world's largest drug market. Several industry executives said teams o
-
USFDA Inspects Ranbaxys New Plant in Mohali
Co may resume supplies to the US nearly 3 years after they were halted from its 2 plants American drug authorities have started inspecting Ranbaxy Laboratories
-
Global Cos Launch Generic Drugs to Take on Desi Firms
Global drugmakers have started launching generic or low-priced version of popular medicines and have slashed prices of their existing products to increase market share in India, taking on local competitors in their own game. French drugmaker Sanofi Aventis has launched a range of generic drugs, some at half the price of competing brands of local companies, while Japan
-
IICT scientist bags Ranbaxy award
Dr S. Chandrashekar, a Director-grade scientist at the Indian Institute of Chemical Technology (IICT) here was selected for the Ranbaxy Research Award for the year 2009. Dr Chandrashekar was chosen for his exemplary work in the area of pharmaceutical sciences, according to a release.
-
HC rejects BMS plea on sale of hepatitis B generic
THE Delhi High Court (HC) has turned down Bristol-Myers Squibb